ArticleJournal of pharmaceutical health care and sciences2026
A comprehensive analysis of community pharmacists' practices, barriers, and strategies in patient education on Saxenda®: a qualitative study.
Article in Journal of pharmaceutical health care and sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSaxenda® side effects are mostly avoidable, and its administration is complex; therefore, patient education by pharmacists is essential to optimize its efficacy and safety. In Iraq, patient education practices remain inconsistent and barriers to effective patient education are unclear.
objectivesTo evaluate the extent of pharmacists’ practices in patient education regarding Saxenda®, including the adequacy and accuracy of the information conveyed, as well as the barriers encountered in delivering this education.
methodsA qualitative study was conducted using face-to-face interviews with a purposive sample of community-pharmacists in Baghdad. The interview guide was validated by a panel of experts. Data analyzed by thematic analysis.
resultsTwenty-two pharmacists participated in this study, and three main themes emerged: The first is the extent of current pharmacists’ Practice in patient education, with most pharmacists reporting proactive patient education, though only 13 were consistently proactive. Inquiries about Saxenda® mainly received from young adult women and primarily centered on its effectiveness and side effects. The second theme is pharmacists’ practice in patient education about Saxenda®, where pharmacists frequently educate their patients about the administration techniques and side effects of Saxenda ® verbally, but the information provided was often incomplete or misleading. Most participating pharmacists recognized the benefits of patient education to both patients and pharmacists. The last theme involves the barriers and challenges in patient education about Saxenda® such as patients’ low health literacy and pharmacists’ workload. Participants emphasized the need for targeted training and education to better equip pharmacists with the necessary knowledge and skills for effective patient education.
conclusionCommunity-pharmacists in Baghdad frequently receive inquiries about Saxenda® from young women. Although they recognize the benefits of patient education, their patient education practices remain inconsistent due to barriers such as high workload and limited health literacy. Targeted training, improved resource support, and supportive policies are essential to enhance pharmacists’ skills and address existing barriers in patient education.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.